This is a real clinical photo from Creasy & Resnik showing a woman during and after an eclamptic seizure (A: during postictal state, B: after recovery with facial edema). I now have everything needed. Here is the full, OB/GYN-focused answer:
Preeclampsia & Eclampsia - OB/GYN Complete Notes
BASIC CONCEPT (Easy Understand)
| Term | Simple Definition |
|---|
| Preeclampsia | High BP + proteinuria (or organ damage) appearing after 20 weeks of pregnancy |
| Eclampsia | Preeclampsia that progresses to grand mal seizures |
| HELLP syndrome | Severe variant: Hemolysis + Elevated Liver enzymes + Low Platelets |
These are pregnancy-specific diseases. They completely reverse after delivery. The placenta is the cause, delivery is the cure.
PATHOPHYSIOLOGY (The "Why")
The Key Problem: Failure of Spiral Artery Remodeling
In normal pregnancy (left), trophoblasts invade and dilate spiral arteries into wide, low-resistance sinusoids. In preeclampsia (right), this invasion fails - arteries stay narrow and coiled, causing placental ischemia.
Step-by-step mechanism:
1. Trophoblast invasion of spiral arteries FAILS
↓
2. Spiral arteries remain narrow and coiled
↓
3. Placenta becomes ischemic (underperfused)
↓
4. Ischemic placenta releases antiangiogenic factors into maternal blood:
- sFlt-1 (soluble fms-like tyrosine kinase-1) → blocks VEGF and PIGF
- Soluble endoglin → blocks TGF-β
↓
5. Widespread MATERNAL ENDOTHELIAL DYSFUNCTION
↓
6. Signs and symptoms of preeclampsia:
- ↑ Vasoconstriction (↑ TXA₂, ↓ PGI₂) → Hypertension
- Endothelial leakage → Proteinuria, Edema
- Platelet activation → Thrombocytopenia, DIC
- Organ hypoperfusion → Liver, Kidney, Brain damage
Key mediators:
-
↓ Prostacyclin (PGI₂) and ↑ Thromboxane A₂ - imbalance causes vasoconstriction
-
sFlt-1 - the most studied marker; levels rise weeks before clinical disease
-
Increased angiotensin II sensitivity - preeclamptic women are hypersensitive to Ang II even from early pregnancy (as early as 10-14 weeks, before clinical signs!)
-
Creasy & Resnik's Maternal-Fetal Medicine
CLASSIFICATION (OB/GYN Standard)
1. Hypertensive Disorders of Pregnancy (Classification)
| Type | Definition |
|---|
| Chronic hypertension | HTN before 20 weeks or pre-existing |
| Gestational hypertension | New HTN ≥ 20 weeks, NO proteinuria/organ damage, resolves postpartum |
| Preeclampsia | HTN ≥ 20 weeks + proteinuria OR end-organ damage |
| Superimposed preeclampsia | Preeclampsia developing on top of chronic HTN |
| Eclampsia | Preeclampsia + seizures |
2. Preeclampsia: Without vs. With Severe Features
ACOG no longer uses the term "mild" - even without severe features, it carries risk.
Diagnostic Criteria for Preeclampsia:
BP (on 2 occasions ≥ 4 hours apart, after 20 weeks):
- Systolic ≥ 140 mmHg OR Diastolic ≥ 90 mmHg
PLUS at least ONE of:
- Proteinuria ≥ 300 mg/24 hr (or protein:creatinine ratio ≥ 0.3, or dipstick 2+)
- OR without proteinuria, any of:
- Platelets < 100,000/µL
- Creatinine > 1.1 mg/dL (new renal insufficiency)
- Liver enzymes > 2x upper limit of normal
- Pulmonary edema
- New-onset cerebral or visual disturbances
Criteria for SEVERE FEATURES:
| Feature | Threshold |
|---|
| Blood pressure | ≥ 160/110 mmHg on 2 occasions ≥ 4 hrs apart |
| Thrombocytopenia | Platelets < 100,000/µL |
| Liver | Enzymes > 2x normal + persistent RUQ/epigastric pain |
| Kidney | Creatinine > 1.1 mg/dL |
| Pulmonary edema | Any |
| Neurological | New headache, visual disturbances, clonus |
Note (OB exam important!): Proteinuria > 5g and fetal growth restriction are NO LONGER criteria for severe features (per current ACOG).
- Creasy & Resnik's Maternal-Fetal Medicine, p. 1055
RISK FACTORS
| Category | Specific Risk Factors |
|---|
| Nulliparity | Biggest single risk - accounts for 32% of cases |
| Previous preeclampsia | 15-25% recurrence risk |
| Multiple gestation | Twins 6.7%, Triplets 12.7%, Quadruplets 20% |
| Chronic HTN | 25% risk of developing superimposed preeclampsia |
| Diabetes mellitus | ~20% overall; up to 70% with nephropathy (Class F/R) |
| Renal disease | High risk, especially with proteinuria |
| Antiphospholipid syndrome | Major risk - also causes recurrent loss |
| SLE | Increased risk; hard to distinguish from lupus flare |
| Age extremes | Very young (primigravidas) and older women |
| Black race | Associated with more severe forms |
| IVF pregnancy | Increased risk |
| Hydatidiform mole | Can present earlier than 20 weeks |
| Family history | First-degree relative with preeclampsia |
CLINICAL FEATURES
A. Symptoms (by system)
| System | Symptoms |
|---|
| CNS | Severe headache (frontal), dizziness, tinnitus, drowsiness, confusion |
| Visual | Blurred vision, scotomata, diplopia, photophobia, even amaurosis |
| GI/Liver | Epigastric pain, RUQ pain, nausea, vomiting, hematemesis |
| Renal | Oliguria, anuria, hematuria |
| Cardiovascular | Tachycardia, dyspnea |
Most women with early preeclampsia are asymptomatic - this is why frequent antenatal visits matter!
B. Signs
- Hypertension (hallmark)
- Edema - especially facial and hand edema (note: edema alone is NOT diagnostic; it occurs in normal pregnancy too)
- Proteinuria on urine dipstick or 24-hr collection
- Brisk deep tendon reflexes and clonus (warning sign of eclampsia)
- Papilledema (severe cases)
Eclampsia - Clinical Picture
A: Postictal state after eclamptic seizure. B: Same patient after recovery, showing classic facial edema.
-
Seizures are grand mal (tonic-clonic) type
-
Preceded by prodrome in 80%: headache, visual changes
-
30% of eclampsia occurs postpartum (90% within 7 days of delivery)
-
Can occur without warning in 20% of cases
-
Progression from preeclampsia to eclampsia is unpredictable
-
Creasy & Resnik's Maternal-Fetal Medicine, p. 1058
PATHOLOGY - ORGAN CHANGES
1. Kidney - "Glomerular Endotheliosis" (Pathognomonic Lesion)
- Swollen endothelial cells occlude capillary lumen
- Protrusion of glomerular tuft into proximal tubule
- Decreased GFR (opposite of normal pregnancy where GFR increases by 40-50%)
- Protein deposits in glomerular basement membrane
- Result: Proteinuria, oliguria, rising creatinine
2. Liver
- 60% of eclamptic women have gross hepatic lesions
- Early: Periportal hemorrhage - vasodilation → hepatocyte displacement
- Late: Hepatic infarction from intense vasospasm
- Hemorrhagic changes in 66%, necrotic changes in 40% of eclamptic women
- Severe: Subcapsular hemorrhage → risk of hepatic rupture (rare but fatal)
3. Brain
- Cerebral vasospasm + loss of autoregulation → cerebral edema
- PRES (Posterior Reversible Encephalopathy Syndrome) - vasogenic parietooccipital edema, typically reversible
- Petechial hemorrhages, white matter necrosis in severe/fatal cases
- Autopsy: white-matter predominant injury, ranging from mild edema to extensive necrosis
4. Placenta
- Multiple infarcts (from chronic hypoperfusion)
- Retroplacental hemorrhage → risk of abruption
- Syncytial knots (ischemic villi)
- Acute atherosis of decidual vessels (fibrinoid necrosis + lipid macrophages)
- Leads to: IUGR, oligohydramnios, fetal distress
5. Coagulation
- DIC in 10% of severe preeclampsia/eclampsia
- Platelet consumption → thrombocytopenia
- Elevated fibrin degradation products
- Microthrombi in liver, kidney
- Overt DIC → spontaneous hemorrhage
HELLP SYNDROME
H = Hemolysis (microangiopathic hemolytic anemia - schistocytes on smear)
EL = Elevated Liver enzymes (AST, ALT > 2x normal)
LP = Low Platelets (< 100,000/µL, often < 50,000)
Occurs in ~10% of severe preeclampsia cases
Clinical presentation:
- May present WITHOUT classic hypertension or proteinuria
- RUQ/epigastric pain + malaise + nausea + vomiting
- Often confused with cholecystitis, hepatitis, or gastritis
- Can present in emergency department
Complications:
- DIC
- Acute renal failure
- Pulmonary edema
- Placental abruption
- Hepatic rupture (rare, surgical emergency)
- Maternal and perinatal mortality
Management: Urgent delivery is the only definitive treatment
INVESTIGATIONS
| Investigation | What to Check | Significance |
|---|
| BP monitoring | Serial readings ≥ 4 hrs apart | Diagnosis |
| Urine protein | 24-hr urine or P:Cr ratio | Diagnosis |
| CBC + platelets | Platelet count, Hb, smear | Thrombocytopenia, hemolysis |
| LFTs | AST, ALT | HELLP, liver involvement |
| Renal | Creatinine, uric acid, BUN | Renal involvement |
| Uric acid | Often elevated early | Early marker (often precedes clinical disease) |
| Coagulation | PT, aPTT, fibrinogen | DIC screening |
| Fetal monitoring | CTG, BPP, Doppler | Fetal wellbeing |
| Ultrasound | Growth, AFI, Doppler | IUGR, oligohydramnios |
| MRI/CT head | If neurological signs | PRES, hemorrhage, edema |
MANAGEMENT
The Definitive Treatment = DELIVERY (delivery of the placenta)
All other treatment is supportive, not curative. The decision is always: maternal risk of continuing pregnancy vs. fetal risk of prematurity.
A. Antihypertensive Therapy
Threshold: BP ≥ 160/110 mmHg = EMERGENCY - must treat within 30-60 minutes
- Goal: SBP < 160 mmHg, DBP < 110 mmHg
- Do NOT lower BP too fast - risk of uteroplacental insufficiency
| Drug | Dose | Route | Notes |
|---|
| Labetalol (1st line) | 10-20 mg IV; repeat 20-80 mg q10-30 min; max 300 mg | IV | Alpha + beta blocker; preserves uteroplacental flow; no neonatal sympathetic blockade |
| Hydralazine (1st line) | 5 mg IV; repeat 5-10 mg q20-40 min; max 20 mg | IV | ACOG endorsed; arteriolar vasodilator; increases uterine and renal blood flow; watch for reflex tachycardia |
| Nifedipine (oral, 1st line) | 10-20 mg orally; repeat in 20 min if needed | Oral | Given before IV access; calcium channel blocker; can cause uterine relaxation (risk of atony) |
| Nicardipine | 5-30 mg/hr infusion | IV | Smooth rapid BP fall; increases renal perfusion |
| Methyldopa | 250-500 mg TDS | Oral | For chronic/maintenance treatment |
| Nitroprusside | 0.3 µg/kg/min infusion | IV | Reserved for refractory cases; cyanide toxicity risk with prolonged use |
Avoid: ACE inhibitors, ARBs (contraindicated - fetal renal toxicity)
B. Seizure Prophylaxis & Treatment: Magnesium Sulfate
MgSO₄ is FIRST-LINE for both prevention and treatment of eclamptic seizures.
Loading dose: 4 g IV over 15-20 minutes
Maintenance: 1-2 g/hour IV infusion
How it works:
- Calcium antagonism → smooth muscle relaxation → peripheral and cerebral vasodilation
- Protects blood-brain barrier → limits cerebral edema
- Increases prostacyclin release from endothelium
- Decreases plasma renin activity
- Central anticonvulsant activity
- Note: Has only modest antihypertensive effect - additional drugs still needed for BP
Who gets prophylaxis?
- Preeclampsia WITH severe features (especially clonus, severe headache, visual scotomata)
- Does NOT need to be given for preeclampsia without severe features (seizure risk is extremely low and drug toxicity occurs in up to 25%)
Monitoring for toxicity:
| Sign | Serum Mg Level |
|---|
| Loss of patellar reflex | 7-10 mEq/L |
| Respiratory depression | 10-13 mEq/L |
| Respiratory arrest | > 15 mEq/L |
| Cardiac arrest | > 15 mEq/L |
Antidote: Calcium gluconate 1 g IV (10 mL of 10% solution) - keep at bedside!
C. Management of an Eclamptic Seizure
Step-by-step protocol:
1. AIRWAY - Position left lateral, suction airway, give O₂
2. SECURE IV ACCESS
3. MgSO₄ 4g IV bolus (if not already on it)
→ If already on MgSO₄: give extra 2g IV
→ If seizure persists: diazepam 5-10 mg IV
4. BLOOD PRESSURE CONTROL - if ≥ 160/110 mmHg
5. FETAL MONITORING - continuous CTG after stabilization
6. DO NOT rush to deliver during the seizure
7. PLAN DELIVERY after maternal stabilization
8. AIRWAY PROTECTION - intubation if needed
Important: 30% of eclampsia is postpartum - continue MgSO₄ for at least 24 hours after delivery.
D. Fluid Management
Key concept: Preeclampsia is a volume-CONTRACTED, NOT volume-depleted state.
- Capillary permeability is increased - IV fluids leak into interstitium
- Do NOT give aggressive IV fluids - risk of pulmonary edema
- Restrict IVF to ~85 mL/hour in severe cases
- Central venous pressure monitoring is NOT routinely indicated
E. Delivery Timing (OB Exam Favourite!)
| Clinical Situation | Gestational Age | Decision |
|---|
| Preeclampsia WITHOUT severe features | ≥ 37 weeks | Deliver |
| Preeclampsia WITHOUT severe features | 34-37 weeks | Expectant management with close monitoring acceptable |
| Preeclampsia WITH severe features | ≥ 34 weeks | Deliver |
| Preeclampsia WITH severe features | < 34 weeks | Individualize - may attempt corticosteroids for lung maturity then deliver |
| HELLP syndrome | Any gestational age | Deliver (emergency) |
| Eclampsia | Any gestational age | Deliver after maternal stabilization |
Mode of delivery: Vaginal delivery is preferred when feasible. Caesarean not mandatory for preeclampsia alone. Decision based on obstetric indications.
F. HELLP Syndrome Management
- Urgent delivery (regardless of gestational age)
- Correct coagulopathy (FFP, platelets if < 20,000-30,000)
- Platelet transfusion for platelets < 20,000-30,000/µL (for delivery)
- MgSO₄ for seizure prophylaxis
- Antihypertensives for severe BP
- No evidence for corticosteroids or plasma exchange improving outcomes
- Refer to tertiary center if local facilities inadequate
PREVENTION
| Intervention | Evidence | Recommendation |
|---|
| Low-dose aspirin (75-150 mg/day, start at 12-16 weeks) | Reduces risk by ~10-20% in high-risk women | ACOG recommended for high-risk women |
| Calcium supplementation | Beneficial in calcium-deficient populations | Recommended where dietary calcium is low |
| Weight loss before pregnancy | Reduces risk in obese women | Counselled pre-conception |
| Antioxidants (Vit C, Vit E) | NOT effective | Not recommended |
| Salt restriction | NOT effective | Not recommended |
Who qualifies for aspirin prophylaxis (ACOG)?
- Any 1 HIGH-risk factor: previous preeclampsia, multifetal gestation, CKD, autoimmune disease (APS, SLE), diabetes, chronic HTN
- Any 2+ MODERATE-risk factors: nulliparity, obesity, family history, Black race, low socioeconomic status, age ≥ 35, IVF
MATERNAL COMPLICATIONS SUMMARY
| Complication | Mechanism |
|---|
| Intracranial hemorrhage | Uncontrolled severe HTN (93% of strokes are hemorrhagic) |
| Stroke | Cerebral vasospasm, hemorrhage |
| Pulmonary edema | Endothelial leakage + iatrogenic fluid overload |
| Acute renal failure | Glomerular endotheliosis + renal vasospasm |
| Hepatic rupture | Subcapsular hematoma → rupture |
| DIC | Endothelial dysfunction → coagulation cascade activation |
| Placental abruption | Vasospasm → retroplacental hemorrhage |
| Maternal death | Intracranial bleed, liver failure, pulmonary complications |
FETAL COMPLICATIONS
| Complication | Cause |
|---|
| IUGR | Placental insufficiency |
| Prematurity | Medically indicated early delivery |
| Placental abruption | Retroplacental hemorrhage |
| Fetal distress/hypoxia | Chronic uteroplacental insufficiency |
| Oligohydramnios | Decreased renal perfusion (fetal) |
| Intrauterine fetal demise | Severe placental compromise |
PROGNOSIS & LONG-TERM EFFECTS
- HTN and proteinuria resolve within 1-2 weeks postpartum in most cases
- No lasting sequelae in uncomplicated cases
- Preeclampsia is a marker for future cardiovascular disease in the mother:
- 2x lifetime risk of hypertension
- 2x risk of ischemic heart disease
- 2x risk of stroke
- Recurrence risk: ~15-25% in future pregnancies; higher if early-onset or severe
QUICK EXAM SUMMARY BOX
PREECLAMPSIA = BP ≥ 140/90 after 20 wks + Proteinuria OR end-organ damage
SEVERE FEATURES = BP ≥ 160/110 OR platelets <100K OR creatinine >1.1
OR liver enzymes >2x OR pulmonary edema OR neuro symptoms
ECLAMPSIA = Preeclampsia + Grand mal seizures
HELLP = Hemolysis + Elevated Liver enzymes + Low Platelets (10% of severe PE)
TREATMENT:
- Definitive = DELIVERY
- Seizure = MgSO₄ (4g IV load → 1-2g/hr)
- BP ≥ 160/110 = Labetalol / Hydralazine / Nifedipine
- Antidote for Mg toxicity = Calcium gluconate 1g IV
DELIVER AT:
- ≥37 wks = any preeclampsia
- ≥34 wks = severe features
- Any gestation = eclampsia, HELLP
Source: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice (primary OB/GYN reference used throughout)